Literature DB >> 6368950

Skeletal growth in experimental uremia.

O Mehls, E Ritz.   

Abstract

Although in recent years experimental work on growth in uremia has clarified many issues, many key questions cannot be answered with available experimental data. In our own studies on subtotally nephrectomized rats, uremic animals consumed less food and grew less. However, although low energy intake diminishes growth, it has not been established that high protein energy intake will normalize growth. We showed that uremia reduced growth (and net protein synthesis) even under conditions of controlled food intake. In renal failure the optimal dietary protein level for growth or for efficiency of utilization has not been established, particularly since protein intake has an independent injurious effect on long-term renal function. Calcium and vitamin D supplements improved growth in uremic rats, but the data cannot easily be extrapolated to humans. The growth-promoting action of 1,25(OH)2D3 was not superior to that of equipotent doses of vitamin D3. Correction of anemia and physical exercise did not improve growth. Diminished stimulation of growth cartilage cyclic AMP with PTH and augmented stimulation with calcitonin was noted in uremic animals. Growth hormone in supraphysiological doses improved growth and raised IGF carrier protein in uremic animals. Spermine, a potential uremic toxin, inhibited growth cartilage 3H-thymidine incorporation, but only in concentrations higher than that encountered in uremia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6368950

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  10 in total

1.  Effect of growth hormone on kidney growth and glomerular structure.

Authors:  W C Arnold; B Shirkey; P Frindik; E Ellis
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

2.  Growth in children with chronic renal failure on intermittent versus daily calcitriol.

Authors:  Claus Peter Schmitt; Gianluigi Ardissino; Sara Testa; Aldo Claris-Appiani; Otto Mehls
Journal:  Pediatr Nephrol       Date:  2003-04-08       Impact factor: 3.714

3.  Recombinant human growth hormone treatment of children following renal transplantation.

Authors:  R N Fine; O Yadin; P A Nelson; K Pyke-Grimm; M I Boechat; B H Lippe; B M Sherman; R B Ettenger; E Kamil
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

4.  Growth of children following the initiation of dialysis: a comparison of three dialysis modalities.

Authors:  B A Kaiser; M S Polinsky; J Stover; B Z Morgenstern; H J Baluarte
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

5.  Growth in renal failure: a longitudinal study of emotional and behavioural changes during trials of growth hormone treatment.

Authors:  R J Postlethwaite; D M Eminson; J M Reynolds; A J Wood; S Hollis
Journal:  Arch Dis Child       Date:  1998-03       Impact factor: 3.791

Review 6.  Recent advances and controversies in childhood renal osteodystrophy.

Authors:  O Mehls; I B Salusky
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

7.  Effects of growth hormone therapy and malnutrition on the growth of rats with renal failure.

Authors:  D R Powell; R G Rosenfeld; R L Hintz
Journal:  Pediatr Nephrol       Date:  1988-10       Impact factor: 3.714

8.  Recombinant human growth hormone treatment of children with chronic renal failure: long-term (1- to 3-year) outcome.

Authors:  R N Fine; K Pyke-Grimm; P A Nelson; M I Boechat; B M Lippe; O Yadin; E Kamil
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

9.  Short dialyzed children respond less to growth hormone than patients prior to dialysis. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.

Authors:  E Wühl; D Haffner; R Nissel; F Schaefer; O Mehls
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

10.  Chronic Low Dose Growth Hormone Treatment Stimulates Both Hypertrophy and Hyperplasia of Remnant Kidneys in Uraemic Rats.

Authors:  J P Frindik; W C Arnold; E Ellis
Journal:  Clin Drug Investig       Date:  1995-09       Impact factor: 2.859

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.